DKC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.215800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.638200E-01
Normal-vs-Stage2
8.770400E-01
Normal-vs-Stage3
2.963200E-01
Normal-vs-Stage4
6.631000E-01
Stage1-vs-Stage2
9.781400E-01
Stage1-vs-Stage3
1.173410E-01
Stage1-vs-Stage4
6.983800E-01
Stage2-vs-Stage3
1.781820E-01
Stage2-vs-Stage4
7.820400E-01
Stage3-vs-Stage4
1.014180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.055200E-01
Normal-vs-AfricanAmerican
8.277600E-01
Normal-vs-Asian
9.352800E-01
Caucasian-vs-AfricanAmerican
8.484000E-01
Caucasian-vs-Asian
6.758200E-01
AfricanAmerican-vs-Asian
7.242000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.941000E-01
Normal-vs-Female
8.396400E-01
Male-vs-Female
3.583000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.925400E-01
Normal-vs-Age(41-60Yrs)
7.122200E-01
Normal-vs-Age(61-80Yrs)
9.117200E-01
Normal-vs-Age(81-100Yrs)
7.596600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.167000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.031400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.595800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.364300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.784200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.442600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.669200E-01
Normal-vs-Daily Drinker
9.282800E-01
Normal-vs-Weekly Drinker
8.073600E-01
Normal-vs-Occasional Drinker
5.324800E-01
Normal-vs-Social Drinker
8.995400E-01
Non Drinker-vs-Daily Drinker
7.862000E-01
Non Drinker-vs-Weekly Drinker
6.373800E-01
Non Drinker-vs-Occasional Drinker
3.503800E-01
Non Drinker-vs-Social Drinker
9.193400E-01
Daily Drinker-vs-Weekly Drinker
5.510000E-01
Daily Drinker-vs-Occasional Drinker
2.348600E-01
Daily Drinker-vs-Social Drinker
7.092800E-01
Weekly Drinker-vs-Occasional Drinker
9.292600E-01
Weekly Drinker-vs-Social Drinker
6.630000E-01
Occasional Drinker-vs-Social Drinker
3.588200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.505000E-01
Normal-vs-Grade 2
6.690200E-01
Normal-vs-Grade 3
6.910800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.737600E-01
Grade 1-vs-Grade 3
5.248300E-02
Grade 1-vs-Grade 4
6.505000E-01
Grade 2-vs-Grade 3
1.617050E-01
Grade 2-vs-Grade 4
6.690200E-01
Grade 3-vs-Grade 4
6.910800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.739000E-01
Normal-vs-NonDiabetic
8.786200E-01
Diabetic-vs-NonDiabetic
2.125000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.457200E-01
Normal-vs-NoPancreatitis
9.544000E-01
Pancreatitis-vs-NoPancreatitis
5.264600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.382200E-01
Normal-vs-N1
8.844800E-01
N0-vs-N1
7.683800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.829400E-01
Normal-vs-TP53-NonMutant
8.831800E-01
TP53-Mutant-vs-TP53-NonMutant
4.499100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
